SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN NONHYPERTENSIVE LEAN NIDDM PATIENTS

被引:1
|
作者
IKEDA, T
OCHI, H
OHTANI, I
FUJIYAMA, K
HOSHINO, T
TANAKA, Y
TAKEUCHI, T
MASHIBA, H
机构
[1] First Department of Internal Medicine, Tottori University School of Medicine, Nishi-machi, Yonago
关键词
APOLIPOPROTEIN; GLYCEMIC CONTROL; HYPERTENSION; NIDDM; PROTEINURIA; SERUM LIPIDS;
D O I
10.1111/j.1365-2796.1991.tb00420.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the possible role of a glycaemic control in lipid metabolism in non-insulin-dependent diabetes mellitus (NIDDM) patients, serum lipid and apolipoprotein levels were measured in well-controlled and poorly controlled lean NIDDM without proteinuria and hypertension. A sample of 96 lean NIDDM patients (body mass index < 25 kg m-2 in men and < 27 kg m-2 in women) were divided into two groups: group I, where the HbA1c concentration had been < 6% for the previous 3 months, and group II, where the HbA1c concentration had been > 8% for the previous 3 months. Serum total cholesterol, triglyceride, and HDL-cholesterol levels showed no significant differences between groups I and II. Furthermore, serum levels of apolipoproteins AI, AII, B, CII, CIII, and E did not differ significantly between groups I and II. These results suggest that glycaemic control did not influence lipid metabolism in lean NIDDM patients.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 50 条
  • [1] SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN A TIBETAN POPULATION-SAMPLE
    KESTELOOT, H
    HUANG, DX
    ZOU, XD
    SONG, A
    COBBAERT, C
    ACTA CARDIOLOGICA, 1990, 45 (06) : 455 - 462
  • [2] SERUM-LIPID AND LIPOPROTEIN LEVELS IN JAPANESE PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    MABUCHI, H
    TATAMI, R
    UEDA, K
    UEDA, R
    HABA, T
    KAMETANI, T
    WATANABE, A
    WAKASUGI, T
    ITO, S
    KOIZUMI, J
    OHTA, M
    MIYAMOTO, S
    TAKEDA, R
    ATHEROSCLEROSIS, 1979, 32 (04) : 435 - 444
  • [3] SHIFTING FROM CONVENTIONAL DIET TO AN UNCOOKED VEGAN DIET REVERSIBLY ALTERS SERUM-LIPID AND APOLIPOPROTEIN LEVELS
    LING, WH
    LIATINEN, M
    HANNINEN, O
    NUTRITION RESEARCH, 1992, 12 (12) : 1431 - 1440
  • [4] Apolipoprotein (a) levels and phenotypes in NIDDM 1 patients with microalbuminuria and albuminuria
    Lam, KSL
    Pang, RWC
    Wat, MS
    Lauder, IJ
    Janus, ED
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (11) : 2229 - 2236
  • [5] SERUM AND URINE MALONDIALDEHYDE LEVELS IN NIDDM PATIENTS WITH AND WITHOUT HYPERLIPIDEMIA
    NACITARHAN, S
    OZBEN, T
    TUNCER, N
    FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (06) : 893 - 896
  • [6] RELATIONS OF BODY-FAT AND FAT DISTRIBUTION TO THE SERUM-LIPID, APOLIPOPROTEIN AND INSULIN CONCENTRATIONS OF SAMOAN MEN AND WOMEN
    GALANIS, DJ
    MCGARVEY, ST
    SOBAL, J
    BAUSSERMAN, L
    LEVINSON, PD
    INTERNATIONAL JOURNAL OF OBESITY, 1995, 19 (10) : 731 - 738
  • [7] THE IMPORTANCE OF DIETARY EICOSAPENTAENOIC TO DOCOSAHEXAENOIC ACID RATIO IN MODULATION OF SERUM-LIPID AND ARACHIDONIC-ACID LEVELS
    GARG, ML
    LI, T
    NUTRITION RESEARCH, 1994, 14 (10) : 1575 - 1582
  • [8] Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
    Boiko, Anastasiia S.
    Mednova, Irina A.
    Kornetova, Elena G.
    Semke, Arkadiy, V
    Bokhan, Nikolay A.
    Loonen, Anton J. M.
    Ivanova, Svetlana A.
    HELIYON, 2019, 5 (07)
  • [9] Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment
    Lacerda, Gilmar de Souza
    Medeiros, Thalia
    do Rosario, Natalia Fonseca
    Saramago Peralta, Regina Helena
    Cabral-Castro, Mauro Jorge
    Cathala Esberard, Eliane Bordalo
    de Andrade, Thais Guarana
    Xavier, Analucia Rampazzo
    Silva, Andrea Alice
    CLINICAL BIOCHEMISTRY, 2018, 60 : 17 - 23
  • [10] Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM
    Kimura, H
    Suzuki, Y
    Gejyo, F
    Karasawa, R
    Miyazaki, R
    Suzuki, S
    Arakawa, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) : 666 - 673